Category: Cancer and Tumor

Science Press Release Distribution Services

Latest Research News on tumor metastasis : Jan 2022

Angiogenesis and Tumor Metastasis Angiogenesis, the recruitment of new blood vessels, is an essential component of the metastatic pathway. These vessels provide the principal route by which tumor cells exit the primary tumor site and enter the circulation. For many tumors, the vascular density can provide a prognostic indicator of metastatic potential, with the highly…
Read more


January 25, 2022 0

Latest Research News on tumor size : Jan 2022

Determination of subcutaneous tumor size in athymic (nude) mice The athymic (nude) mouse is a useful model for studying the biology and response to therapies of human tumors in vivo. A survey of recent literature revealed the use of 19 different formulas for determining the size of subcutaneous tumors grown as xenografts in nude mice…
Read more


January 17, 2022 0

Latest Research News on skin cancer : Jan 2022

The epidemiology of skin cancer Summary Melanoma and non-melanoma (basal and squamous cell carcinoma) skin cancer (NMSC) are now the most common types of cancer in the white populations and the incidence of skin cancer has reached epidemic proportions. According to recent population-based studies from Australia the incidence rate is over 2% for basal cell…
Read more


January 15, 2022 0

Latest Research News on cancer mortality : Jan 2022

Trends in cancer incidence and mortality Time trends in cancer risk have often been summarised by the observation that mortality from cancers associated with tobacco is increasing rapidly, while mortality from all other cancers is either stable or falling slightly, this slight decline being dominated by the decrease in mortality from stomach cancer. Until recently,…
Read more


January 12, 2022 0

Latest Research News on Medulloblastoma : Jan 2022

Medulloblastoma Medulloblastoma is the most common malignant brain tumor in children. Patients with medulloblastoma are stratified into ‘‘standard’’ and ‘‘high’’ risk categories based on age at diagnosis, degree of surgical resection, and disease spread. In children older than 3 years of age, the long-term survival can be achieved in approximately 85% of standard risk patients…
Read more


January 11, 2022 0

Latest Research News on Neuroendocrine Carcinoma : Jan 2022

Gastroenteropancreatic high-grade neuroendocrine carcinoma Gastroenteropancreatic (GEP) neuroendocrine neoplasms are classified as low-grade, intermediate-grade, and high-grade tumors based on morphologic criteria and the proliferation rate. Most studies have been conducted in patients with well differentiated (low-grade to intermediate-grade) neuroendocrine tumors. Data are substantially scarcer on poorly differentiated, high-grade neuroendocrine carcinoma (NEC), which includes the entities of…
Read more


January 10, 2022 0

Latest Research News on Prostate Cancer : Jan 2022

Epidemiology of prostate cancer Prostate cancer incidence and mortality rates vary worldwide. In the United States, prostate cancer is the most common malignancy affecting men and is the second-leading cause of cancer death. Risk of developing prostate cancer is associated with advancing age, African American ethnicity, and a positive family history, and may be influenced…
Read more


January 8, 2022 0

Latest Research News on Breast Cancer : Jan 2022

Cyclins and Breast Cancer The D-type and E-type cyclins control the G1 to S phase transition during normal cell cycle progression and are critical components of steroid- and growth factor-induced mitogenesis in breast epithelial cells. Mammary epithelial cell-specific overexpression of these genes leads to mammary carcinoma, while in cyclin D1-deficient mice mammary gland development is…
Read more


January 7, 2022 0

Latest Research News on Cell Carcinoma : Jan 2021

Renal cell carcinoma Considerable progress has been made in the treatment of patients with renal cell carcinoma, with innovative surgical and systemic strategies revolutionising the management of this disease. In localised disease, partial nephrectomy for small tumours and radical nephrectomy for large tumours continue to be the gold-standard treatments, with emphasis on approaches that have…
Read more


January 6, 2022 0

Latest Research News on Tumor Vasculature: Feb 2021

Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy Solid tumors require blood vessels for growth, and many new cancer therapies are directed against the tumor vasculature. The widely held view is that these antiangiogenic therapies should destroy the tumor vasculature, thereby depriving the tumor of oxygen and nutrients. Here, I review emerging evidence…
Read more


March 1, 2021 0